Health Condition 1: H00-H59- Diseases of the eye and adnexa
Conditions
Interventions
Intervention1: Dexmedetomidine 2mcg/kg: Group 2: Dexmed 2mcg/kg in 0.9% saline (3ml) nebulized over 15 minutes, 30 minutes before induction of anaesthesia.
Intervention2: Dexmedetomidine 3mc/kg: Group
Sponsors
Postgraduate Institute of medical education and research
Eligibility
Inclusion criteria
Inclusion criteria: 99 ASA I & II pediatric patients, in the age group of 3 - 7 years, undergoing general anesthesia
Exclusion criteria
Exclusion criteria: Known allergy or hypersensitivity to dexmedetomidine. Any obvious aberrant nasal anatomy Acute or chronic nasal trauma that may preclude adequate intranasal delivery of drug Patients with anticipated difficult airway Organ dysfunction-Liver dysfunction, Cardiac arrhythmias, congenital heart disease, mental retardation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation scoreTimepoint: 30 minutes after nebulization | — |
Secondary
| Measure | Time frame |
|---|---|
| Emergence time, Emergence agitation, hemodynamic parameters, postoperative painTimepoint: In the postoperative period at immediate postoperative, 5 minutes, 15 minutes and 30 minutes, 1 hour and 2 hours after surgery.;Parental separation score, Mask acceptance scoreTimepoint: 2 minutes before induction of anaesthesia | — |
Countries
India
Contacts
Public ContactDr Divya Jain
PGIMER
Outcome results
None listed